Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
    Veterinary regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Glossaries
    • About this website
    • Data protection and privacy
    • FAQs
    • Contacts

COVID-19 pandemic

All info here

QUICK LINKS

  • Latest updates
  • Vaccines
  • Treatments
  • Guidance for developers and companies
  • Find information on all EU veterinary medicines
    Video on all EU veterinary medicines
    Veterinary Medicines |Video

    Find information on all EU veterinary medicines

  • Find information on all EU veterinary medicines
    Video on all EU veterinary medicines
    Veterinary Medicines |Video

    Find information on all EU veterinary medicines

    Two websites help farmers, pet owners and veterinarians make informed decisions to protect the health of their animals. To find out more, watch the video

  • Call for companies to register their i-SPOC
    i-SPOC registration for companies
    EXTENDED MANDATE |SHORTAGES

    Call for companies to register their i-SPOC

  • Call for companies to register their i-SPOC
    i-SPOC registration for companies
    EXTENDED MANDATE |SHORTAGES

    Call for companies to register their i-SPOC

    Marketing authorisation holders are invited to register their Industry Single Point of Contact on shortages in EMA’s IRIS platform. Deadline for registration is 2 September 2022

  • EMA’s response to monkeypox
    Imvanex
    Monkeypox |Extended mandate

    EMA’s response to monkeypox

  • EMA’s response to monkeypox
    Imvanex
    Monkeypox |Extended mandate

    EMA’s response to monkeypox

    Declaration of public health emergency triggers a series of new actions for a coordinated response

  • EMA and ECDC update on COVID-19 booster doses
    EMA and ECDC update on COVID-19 booster doses
    COVID-19 |Vaccines

    EMA and ECDC update on COVID-19 booster doses

  • EMA and ECDC update on COVID-19 booster doses
    EMA and ECDC update on COVID-19 booster doses
    COVID-19 |Vaccines

    EMA and ECDC update on COVID-19 booster doses

    The two EU agencies recommended considering second boosters of mRNA vaccines in people aged 60 to 79 and those at risk of severe disease

Search for medicines
Search for information on human, veterinary or herbal medicines.
What's new
Find all the latest news and updates published on this website in one place.
FAQs
Find answers to the most frequently asked questions we receive.

Latest news

  • List item
    28/07/2022

    Big data use for public health: publication of Big Data Steering Group workplan 2022-25

    The Big Data Steering Group set up by EMA and the Heads of Medicines Agencies (HMA) has published its third workplan that sets key actions to be delivered between 2022–25. The new workplan will allow to further enhance the efficient integration of...

  • List item
    27/07/2022 COVID-19

    EMA reviewing data on sabizabulin for COVID-19

    EMA’s Emergency Task Force (ETF) has started a review of data on the use of sabizabulin for treating COVID-19. The review will look at all available data, including data from a study involving hospitalised patients with moderate-to-severe COVID-19...

  • List item
    27/07/2022

    EMA response to the monkeypox public health emergency

    The European Medicines Agency (EMA) has initiated a series of actions to respond to the ongoing monkeypox outbreak, which has been escalated by the World Health Organization (WHO) to a Public Health Emergency of International Concern (PHEIC) on...

  • List item
    25/07/2022

    EMA Paediatric Committee elects Brian Aylward as its new Chair

    At its July 2022 meeting, EMA’s Paediatric Committee (PDCO) elected Brian Aylward from Ireland as its new chair for a three-year mandate. Dr Aylward takes over from Professor Koenraad Norga from the Federal Agency for Medicines and Health Products (...

  • List item
    22/07/2022

    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2022

    11 new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended 11 medicines for approval at its July 2022 meeting. The CHMP recommended granting a marketing authorisation for Amvuttra * (vutrisiran) for the treatment of...

  • List item
    22/07/2022

    New medicine for multiple myeloma patients with limited treatment options

    EMA has recommended a conditional marketing authorisation in the European Union (EU) for Tecvayli (teclistamab) for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies,...

  • Load more news

Information for you

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of medicine development

Key content

  • List item

    Product emergency hotline

  • List item

    UK’s withdrawal from the EU

  • List item

    PRIME: Priority medicines

  • List item

    Pharmacovigilance (safety monitoring)

  • List item

    Data on medicines

  • List item

    Clinical data publication

  • List item

    Careers

Services & databases

  • List item

    Clinical Trials website

  • List item

    Account Management portal

  • List item

    eSubmission

  • List item

    EudraVigilance (human)

  • List item

    EudraVigilance Veterinary

  • List item

    Veterinary Medicines information website

  • List item

    Suspected adverse drug reactions database

  • List item

    Clinical data

  • List item

    SPOR data management services

  • List item

    Service Desk

  • List item

    IRIS platform

  • List item

    Public register of parallel distribution notices

  • List item

    European Vaccination Information Portal

How does EMA work?

  • List item

    What we do

  • List item

    Our role in authorisation of medicines

  • List item

    Who we are

  • List item

    Our scientific experts

  • List item

    How we work

  • List item

    What we publish

Product emergency hotline
outside working hours
  • About us
  • What we do
  • Careers
  • Committees
  • Regulatory network
  • Frequently asked questions
  • Search tips
  • Glossaries
  • About this website
  • Privacy
  • Access to documents
  • Contacts
  • Send a question
  • EMA Service Desk (system support)

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

How to find us

Postal address and deliveries

Business hours and holidays

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
RSS feed Twitter YouTube LinkedIn
© 1995-2022 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag